Le Lézard
Classified in: Health
Subjects: CPG, MAT

Premiers Focused on Public Health and Safety in the Legalization of Cannabis


SASKATOON, July 11, 2019 /CNW/ - The federal government legalized cannabis in October 2018. Premiers remain focused on protecting public health and safety, and combatting the illegal market for cannabis. Provinces and territories are responsible for significant aspects of this complex undertaking, and substantial costs have been incurred.

Premiers discussed the considerable progress provinces and territories have made in developing cannabis distribution, retail and oversight mechanisms under very tight federal timelines. However, they emphasized the need for the federal government to quickly address several outstanding concerns to support the health and safety of Canadians:

 

SOURCE Canada's Premiers


These press releases may also interest you

at 05:05
By using single-cell analysis to measure metabolic activities in rare disseminated tumor cells taken from non-small cell lung cancer (NSCLC) patients, Institute for Systems Biology (ISB) researchers and their collaborators can accurately predict how...

at 05:00
August 26, 2019 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced that Daniela Seabrook will succeed Ronald de Jong as Chief Human Resources Officer, effective January 1, 2020. In this role, Mrs....

at 04:26
The global Regenerative Medicine Market is likely to expand considerably in the coming years due to growing applications in the treatment of chronic diseases. According to a report published by Fortune Business Insights, titled "Regenerative Medicine...

at 04:15
Arcadia Biosciences, Inc. , a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that Raj Ketkar, president and CEO, will retire effective September 1, 2019. In line with...

at 04:00
Arcadia Biosciences, Inc. , a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling...

at 03:50
CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient in China has been dosed in the Phase I/II bridging study of avapritinib, which was discovered by CStone's partner Blueprint Medicines. This stand-alone...



News published on 11 july 2019 at 16:53 and distributed by: